Zurueck zur Suche

Reporte zur Charge 977EN

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

14Reporte angezeigt
0Todesfaelle
3Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 3 MI 1 IN 1 AZ 1 AL 1 DC 1 OH 1 LA 1 IL 1 NY 1 NJ 1 MN 1

VAERS 2473446

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 977EN

kritisch
Staat
MI
Alter
27,0
Geschlecht
F
Eingang
10.10.2022
Impfdatum
05.01.2022
Beginn
29.09.2022
Tage bis Beginn
267,0
Dosis
N/A
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory failure Asthma Blood bicarbonate decreased Blood lactic acid decreased Blood urea decreased C-reactive protein increased COVID-19 Chest X-ray normal Chills Condition aggravated Cough Decreased appetite Diarrhoea Dyspnoea Fibrin D dimer Laboratory test Oropharyngeal pain Oxygen saturation decreased

Symptomtext

Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 9/29/2022 Discharge Date: 10/2/2022 PRESENTING PROBLEM: Acute respiratory failure with hypoxia COVID-19 virus infection COVID-19 HOSPITAL COURSE: Patient is a 28 y.o. female PMH asthma taking QVAR who presents today with shortness of breath. Patient is vaccinated for COVID-19 with posterior. Patient states that up until Tuesday 09/27/2022 she had been in her usual state of health. She and her boyfriend went to the zoo on Tuesday. Within several hours of returning home patient started to experience sore throat, body aches, decreased appetite and chills. On 09/28/2022 she started to experience increased shortness of breath, wheezes, cough. She required home nebulizer treatment 5 times on Wednesday. She stated that on Wednesday body aches worsened. Today, patient required 7 nebulizer treatments to improve shortness of breath. She stated that this improved his shortness of breath for about an hour max. Wheezing, shortness of breath, cough would reoccur within 15-30 minutes. She also started to develop diarrhea. She took a home COVID test which was positive. The patient decided to seek further care in the ER. Initial vitals in ER were reassuring. Labs notable for bicarb 19, BUN 7, CRP 19.5, lactic 1.1, WBC 5.57. D-dimer 340. Chest x-ray negative for acute process. Patient had improved with albuterol treatments while in the ER. However when obtaining a ambulatory pulse ox, patient's oxygen saturation decreased to 86% she was placed on 2 L nasal cannula oxygen saturating in the low 90s. Additionally patient became afebrile with temp of 37.8. While in the ER, patient received acetaminophen 1000 mg orally, methylprednisolone 125 mg IV. Hospitalist asked to admit patient for management of asthma exacerbation and COVID-19. Patient was treated with dexamethasone and remdesivir and respiratory treatments. Her symptoms improved and she was weaned off oxygen. She was able to tolerate a solid diet. She did not qualify for home oxygen. Patient was discharged home in good condition

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Asthma COVID-19 Acute respiratory failure with hypoxia
Andere Medikamente
albuterol (PROVENTIL) (2.5 MG/3ML) 0.083% nebulization albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler beclomethasone diprop HFA (QVAR REDIHALER) 40 MCG/ACT inhaler benzonatate (TESSALON) 100 MG capsule
Allergien
None
Vorherige Impfungen
-

VAERS 2131042

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 977EN

schwer
Staat
IN
Alter
1,3
Geschlecht
M
Eingang
22.02.2022
Impfdatum
14.02.2022
Beginn
17.02.2022
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Blood glucose normal Body temperature increased Fatigue Gaze palsy Generalised tonic-clonic seizure Irritability Malaise Pallor Pyrexia Roseola Tremor

Symptomtext

Received vaccine 2/14/22. A little tired on the day of the vaccine and for the next 24 hours. 2/17/22 he was acting like he was not feeling well, temp 101. No other symptoms. Took tylenol at 12 pm. At 3:50 pm he was fussing, eyes rolled back and started shaking. lasted about 1-2 minutes. Was tired and slept more afterwards. Fever continued on and off for the next 24 hours. Patient was transported to the ER by ambulance after the seizure. Reported as tonic clonic seizure. He did not stop breathing, no emesis. No other symptoms. Patient later seen in PCP office on 2/21/22 for follow up. 2/21/22 patient had scattered blanching macules on chest, abdomen, and back. The physician suspects roseola.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Generalised tonic-clonic seizure
Hospital-Tage
-
Labordaten
En Route Blood Sugar 66; 4 oz of apple juice given and blood sugar 152 in ER 2/17/22 Denied wanting Viral Panel done
Aktuelle Erkrankungen
Suspected Roseola
Vorgeschichte
Congenital hydronephrosis
Andere Medikamente
OTC tylenol PRN
Allergien
none
Vorherige Impfungen
-

VAERS 1906071

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 977en

moderat
Staat
AZ
Alter
65,0
Geschlecht
M
Eingang
29.11.2021
Impfdatum
29.11.2021
Beginn
29.11.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chest pain

Symptomtext

called at 1:25 pm stating that a couple hours after receiving the vaccine he had sharp pains on the left side of his chest. He states he had about 4 episodes where he had 2-3 sharp pains each. At 2:15 pm when I spoke to him he hadn't had any further episodes but stated if he needed to he would go to urgent care or seek medical treatment as I had advised since this is not an expected side effect.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
None
Allergien
None listed
Vorherige Impfungen
-

VAERS 1808369

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 977EN

moderat
Staat
AL
Alter
56,0
Geschlecht
M
Eingang
22.10.2021
Impfdatum
22.10.2021
Beginn
22.10.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Back pain Dyspnoea Hypoaesthesia Pain

Symptomtext

Patient called the pharmacy and reported having pain 8/10, difficulty breathing deeply, and shoulder pain radiating to her back with some numbness in the arm that was vaccinated. I told her to immediately seek medical attention (told her to go to the ED) due to the difficulty breathing.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
No known illnesses at time of vaccination or 1 month prior.
Vorgeschichte
Asthma and allergic rhitinits.
Andere Medikamente
Prescription medications: Albuterol HFA inhaler; Cephalexin 500mg (1 BID for 5 days); Mupirocin 2% ointment; Ventolin HFA inhaler
Allergien
No known drug allergies
Vorherige Impfungen
-

VAERS 1923356

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 977EN

mild
Staat
DC
Alter
27,0
Geschlecht
F
Eingang
04.12.2021
Impfdatum
11.11.2021
Beginn
26.11.2021
Tage bis Beginn
15,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Angiogram Anticoagulant therapy Arthralgia Autoimmune disorder Bedridden Blood test C-reactive protein increased Chest X-ray Chills Computerised tomogram Electrocardiogram Gait inability Headache Infection Influenza virus test negative Joint swelling Magnetic resonance imaging Muscular weakness

Symptomtext

PATIENT REPORTED: 2.5 weeks after vax date, Headache, chills, fevers, body aches, joint pain, bed ridden for 6 days (3 of them in the hospital); tested negative for COVID AND FLU; ELEVATED CRP; ELEVATED SEDIMENTATION RATE; ELEVATED RF; TYLENOL, IV TORADOL, SUSPECTED INFECTION; RELEASED FROM HOSPITAL AFTER 4 HOURS AND WAS ASKED RETURN IF SYMPTOMS GOT WORSE. THE NIGHT RELEASED, COULDN'T WALK , PAIN AND WEEKENESS IN LEGS, RETURNED TO ER; SUSPECTED AUTOIMMUNE DISEASE OR REACTION TO FLU VACCINE OR COVID VACCINE; PRESCRIBED MEDROL PACK, ZOFRAN IV, TABLET, BLOOD THINNERS (SQ) CAN'T REMEMBER THE NAME OF THE BLOOD THINNER, IV MORHPINE, IV ANTIBIOTICS, FIORICET, SOME ANTI ANXIETY; XRAY WAS DONE TO RULE OUT PNEUMONIA, ALSO ON LEFT KNEE FOR ACHES AND SWELLING; MRI, CT SCAN, EKG, MRA, BLOOD TESTS, 2 URINE SAMPLES; NO SIMILAR REACTION IN PRIOR YEARS FOR FLU VACCINATION; 4 WEEKS BEFORE THE INCIDENCE (OCT 27, 2021)COVID BOOSTER WAS ADMINSTERED AT PHARMACY(MODERNA BOOSTER - MORE THAN 6 MONTHS AFTER THE INITAL 2 DOSES OF PFIZER); STILL RECOVERING

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
3,0
Labordaten
PLEASE REFER TO THE ABOVE
Aktuelle Erkrankungen
NONE; COVID BOOSTER 2 WEEKS BEFORE (OCTOBER 25TH)
Vorgeschichte
OCD & ANXIETY
Andere Medikamente
SERTRALINE 50 MG; VITAMIN C AND D3; ASHEWAGANDA; IUD (MIRINA)
Allergien
OXYCODONE
Vorherige Impfungen
2ND COVID VACCINE HAD CHILLS, FEVERS, BODY ACHES.... NOTHING SERIOUS

VAERS 1868327

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 977EN

mild
Staat
OH
Alter
60,0
Geschlecht
F
Eingang
14.11.2021
Impfdatum
09.11.2021
Beginn
13.11.2021
Tage bis Beginn
4,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Eye swelling Ocular hyperaemia Periorbital swelling Pruritus Rash

Symptomtext

Patient reported to my pharmacy at 5:30pm on Saturday 11/13/2021. Upon greeting patient, I noted red, puffy eyes as well as a rash that developed on both hands. Patient stated that the rash and puffy eyes developed earlier that morning on 11/13/2021 and was persistent all day. I instructed the patient to take some Benadryl that evening and use hydrocortisone cream on the itchy areas of the hands and arms. I reached out to the patient on 11/14/2021 at 1:00pm and spoke directly with the patient who told me that on the night of 11/13/2021 before they took the benadryl their eyes were notably swollen, worse than when she had arrived at the pharmacy around 5:30 that day. This morning (11/14) the patient noted that the eye swelling had gone down considerably but the rash was still persistent. I instructed the patient to continue with the benadryl and I will have my pharmacist on duty 11/15 check in with them and give further instructions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None noted
Vorgeschichte
None noted
Andere Medikamente
None noted
Allergien
None noted
Vorherige Impfungen
-

VAERS 1855290

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 977en

mild
Staat
TX
Alter
14,0
Geschlecht
F
Eingang
09.11.2021
Impfdatum
18.10.2021
Beginn
18.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Nasal congestion Paranasal sinus discomfort Rhinorrhoea

Symptomtext

Mom indicated that same day of vaccine patient started feeling lightheaded with some dizziness and that the lightheadedness has been ongoing. Mom indicated that patient had seasonal allergies as well and had no relief from taking Benadryl. Advised mom that lightheadedness may be due to some nasal congestion from seasonal allergies and may consider taking fluticasone nasal spray to help relieve the sinus pressure, mucus production, and other accompanying symptoms. Mom agreed to have patient utilize the fluticasone and follow-up with doctor if symptoms did not resolve.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none indicated
Vorgeschichte
seasonal allergies
Andere Medikamente
non given
Allergien
none given
Vorherige Impfungen
-

VAERS 1813789

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 977EN

mild
Staat
TX
Alter
64,0
Geschlecht
F
Eingang
24.10.2021
Impfdatum
22.10.2021
Beginn
24.10.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site inflammation Injection site pain

Symptomtext

Patient returned to pharmacy reporting redness, tenderness, and inflammation at site of injection. Patient indicated some pain when sleeping on the site of injection. Advised to use a warm cloth to reduce tenderness.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none provided on VAR
Vorgeschichte
none provided on VAR
Andere Medikamente
unknown
Allergien
none provided on VAR form
Vorherige Impfungen
-

VAERS 1813588

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 977EN

mild
Staat
LA
Alter
41,0
Geschlecht
F
Eingang
23.10.2021
Impfdatum
21.10.2021
Beginn
22.10.2021
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Headache Injection site pain Myalgia Pyrexia

Symptomtext

Soreness at injection site on 10/22/2021 Fatigue, headache, muscle aches, fever, soreness at injection site on 10/23/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
COVID-19 (2.5 weeks prior)
Vorgeschichte
Asthma, allergies, chronic back pain/ridiculopathy
Andere Medikamente
Vitamin a, d, multi, calcium, singulair (10mg)
Allergien
None
Vorherige Impfungen
Flu vaccine

VAERS 2177728

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 977EN

gering
Staat
IL
Alter
5,0
Geschlecht
F
Eingang
14.03.2022
Impfdatum
05.03.2022
Beginn
05.03.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

New patient came to clinic to establish care with Aunt. No vaccine records presented when intake was done. Later during the visit-mother arrived with vaccine and records. CMA placed all records on RN desk. (RN was with another patient). When RN saw vaccine records she entered all vaccines in chart. Per vaccine records patient was to receive an MMR. The RN did not see the records that reflected that the child had received 2 MMR's. Pediatrician informed immediately upon realization of error. Child returned to clinic 3/08/22. Aunt stated child did not have any adverse effects and was feeling well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 2119044

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 977EN

gering
Staat
NY
Alter
4,0
Geschlecht
M
Eingang
17.02.2022
Impfdatum
31.01.2022
Beginn
02.02.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Cellulitis Vaccination complication

Symptomtext

Cellulitis of left upper extremity ; Post vaccination reaction . Patient got admitted in Hospital for 4 days and required IV antibiotics.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cellulitis
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
-
Allergien
none
Vorherige Impfungen
-

VAERS 1994512

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 977EN

gering
Staat
NJ
Alter
22,0
Geschlecht
F
Eingang
31.12.2021
Impfdatum
02.11.2021
Beginn
12.12.2021
Tage bis Beginn
40,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy Extra dose administered No adverse event

Symptomtext

This prospective pregnancy case was reported by a nurse via call center representative and described the occurrence of vaccine exposure during pregnancy in a 22-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2021-2022 season) (batch number 977EN, expiry date 30th June 2022) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis and INFLUENZA VIRUS VACCINE INACTIVATED (FLUZONE (SEASONAL INFLUENZA VACCINE)) for prophylaxis. On 12th December 2021, the patient received the 2nd dose of Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device. On 2nd November 2021, the patient received FLUZONE (SEASONAL INFLUENZA VACCINE). The patient's last menstrual period was on an unknown date and estimated date of delivery was on an unknown date. The patient received Fluarix Quadrivalent 2021-2022 season at an unknown time during the pregnancy. On 12th December 2021, unknown after receiving Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced extra dose administered. On an unknown date, the patient experienced vaccine exposure during pregnancy. On an unknown date, the outcome of the vaccine exposure during pregnancy and extra dose administered were unknown. The pregnancy was ongoing. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: Nurse called to report that a medical assistant administered a pregnant patient the FLUARIX vaccine (on the day of reporting) and after administration found out that the patient had received FLUZONE vaccine, which led to extra dose administered. 28 weeks and 1 day pregnant at exposure to Fluarix vaccine. Nurse would like to know if there were any adverse events that had been reported after administering 2 flu vaccines. Call abandoned whilst warm transferring call to Medical Information. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1883964

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 977EN

gering
Staat
TX
Alter
-
Geschlecht
M
Eingang
19.11.2021
Impfdatum
11.11.2021
Beginn
11.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

On 05Oct2021 patient received Fluzone, on 11Nov2021 received Fluarix; This case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 48-year-old male patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number 977EN, expiry date 30th June 2022) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. Concomitant products included INFLUENZA VIRUS VACCINE INACTIVATED (FLUZONE (FLU SHOT)). On 11th November 2021, the patient received Fluarix Tetra 2020-2021 season (intramuscular) and Fluarix Tetra Pre-Filled Syringe Device. On 11th November 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The patient received Fluarix Tetra in the left deltoid. The patient received the Fluzone flu shot, however the patient inadvertently received a second flu shot, Fluarix, which led to extra dose administered. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
FLUZONE (FLU SHOT)
Allergien
-
Vorherige Impfungen
-

VAERS 1804712

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 977en

gering
Staat
MN
Alter
37,0
Geschlecht
M
Eingang
21.10.2021
Impfdatum
20.10.2021
Beginn
20.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Productive cough

Symptomtext

After receiving the immunizations the patient noted phlegm in his throat that was different than before receiving the vaccines. He was given 50mg diphenhydramine and observed for an additional 15 minutes. After feeling well following observation he returned home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Productive cough
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Keflex
Vorherige Impfungen
-